Solitary Pulmonary Nodule (SPN) Flashcards
What are the characteristics of a solitary pulmonary nodule on CXR
Coin lesion
1. Under 3 cm
2. Isolated
3. Rounded opacity
4. Visible on chest CXR / CT surrounded by healthy lung tissue
5. Asymptomatic
What is the etiology of SPN
Possible malignant
*dependent on patient population
Possibly benign
*most SPN are infectious granulomas
*around 5% are benign neoplasm
What is the evaluation goal of SPN
- Avoid invasive procedures if benign
*justify observation, identify and respect malignant SPN in those who will benefit - Look at old imaging studies
What will influence the SPN
- Patient age (Rare under 30)
- Known tobacco use
- Prior malignancies
What percentage of SPN have a potential for malignancy
10 to 68%
What can be used to diagnose a SPN
- History and Physical examiantion
- Review prior imaging
*size, shape, calcification
What is the estimation of doubling when considering if a SPN is malignant
Rapidly growing
*doubling time <30 days (infection)
Stable lesion
*doubling time >465 days (benign)
How does size correlate to malignancy rate
- Size 2 to 5mm (1% malignancy rate)
- Size 6 to 10mm (24 % malignancy rate)
- Size 11 to 20mm (malignancy rate 33%)
- Size 21 to 45mm (malignancy rate 80%)
What are the benign and malignant calcification patterns of SPN
Benign
*dense in a central or laminated pattern
Malignant
*sparse calcification, stippled or eccentric
*cavitary lesions with thick walls (over 16mm)
How does the SPN shape determine if its benign or malignant
Benign
*smooth, well-defined edge
Malignant
*ill defined margins
*spiculated, lobular, perioheral halo
How to determine tx of SPN
- Establish probability of malignancy form clinical and radiologic info
*low
*intermediate
*high - All patients must have estimate of likelihood of malignancy
- Chest CT indicated for any sus SPN
How to be considered a low probability of cancer
- <30
- Lesion stable >2 years
- Expected pattern of benign calcification
What is the management for “low” probability cancer
- Serial imaging studies at regular intervals
*every 3 months for 1 year
*then every 6 months for a second year - Consider high resolution CT early on to obtain a more detailed baseline image
What are the recommendations of management for intermediate probability of cancer
Obtain a diagnostic biopsy
1. Transthoracic needle aspiration (TTNA)
*higher diagnostic yield
*false positive rates (20-30%)
*complications are higher
2. Bronchoscopy
*diagnosis 10-80% of the time
*results for lesions under 2cm is low
*complications are low
What are other options to screen for intermediate probability of cancer
- Positron emission tomography (PET)
*good if inconclusive CT
*disadvantages, false negatives can occur, not for SPN under 1cm - Sputum cytology (central lesions)
*very specific lack sensitivity
*for patients who cannot tolerate invasive diagnostics - Video assisted thoracoscopic surgery (VATS) resection